Management of disease-modifying therapies in multiple sclerosis and comorbid rheumatoid arthritis

Management of disease-modifying therapies in multiple sclerosis and comorbid rheumatoid arthritis

Abstract Background Comorbid autoimmune disorders, including rheumatoid arthritis (RA), are common in people with multiple sclerosis (MS). Both conditions share pathogenic similarities, enabling potential overlap in treatments. While numerous disease-modifying therapies (DMT) are approved for MS and...

Full description

Saved in:
Bibliographic Details
Main Authors: Franz Felix Konen, Torsten Witte, Diana Ernst, David Hagin, Konstantin Fritz Jendretzky, Nora Möhn, Sandra Nay, Lea Grote-Levi, Kurt-Wolfram Sühs, Luisa Klotz, Steffen Pfeuffer, Refik Pul, Christoph Kleinschnitz, Marc Pawlitzki, Sven G. Meuth, Thomas Skripuletz
Format: Article
Language:English
Published: BMC 2025-07-01
Series:Neurological Research and Practice
Subjects:
Multiple sclerosis
Rheumatoid arthritis
Disease-modifying therapy
Autoimmune disorders
Treatment
Beneficial and adverse effects
Online Access:https://doi.org/10.1186/s42466-025-00414-y
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first

Similar Items